What is the clinical significance of detecting stx1 and/or stx2 genes in a Shiga toxin‑producing Escherichia coli isolate that is negative for the O157 serotype?

Clinical significance of stx1/stx2 with negative E. coli O157

• Bold takeaway: A stool positive for stx1 and/or stx2 with negative O157 indicates a non‑O157 STEC infection, which still carries risk for HUS—highest when stx2 is present—and should trigger supportive care (no antibiotics), early volume expansion, close monitoring, and public health notification 1.

What it means

• Non‑O157 STEC (e.g., O26, O45, O103, O111, O121, O145) cause clinically significant disease including bloody diarrhea and HUS; virulence varies by toxin profile 1.
• stx2 positivity is most associated with severe outcomes (HUS, hospitalization, bloody diarrhea); stx1‑only infections tend to be milder but still pathogenic 1, 2.
• O157 negativity does not lower risk if stx2 is detected; some non‑O157 strains cause HUS at rates approaching O157 1.

Immediate management (prioritizing morbidity, mortality, QOL)

1. Do not give antibiotics or antimotility agents; they may worsen outcomes in STEC 1.
2. Start early IV isotonic fluids if dehydration or high‑risk features to reduce renal injury risk 1.
3. Monitor for HUS for at least 7–10 days from diarrhea onset:
   • CBC, platelets, creatinine, urinalysis daily if severe or stx2+; educate for decreased urine, pallor, bruising 1.
4. Infection control: exclude from high‑risk settings (food handling, childcare, healthcare) until cleared per local policy; notify public health promptly 1.

Laboratory/diagnostic actions

• Confirm and characterize:
  • Request culture with isolation and serogrouping; send to public health lab for full typing (O serogroup, stx type, eae) and molecular characterization to aid outbreak detection 1.
  • Use Shiga toxin EIA and/or PCR; PCR stx typing improves detection, especially for stx2, and helps risk stratify follow‑up 1, 3.
• Continue simultaneous O157 culture plus toxin testing on stools in acute community‑acquired diarrhea to detect both O157 and non‑O157 STEC 1.

Risk stratification by toxin result

• stx2 present (with or without stx1): highest risk for HUS; intensify monitoring and hydration strategy 1, 2.
• stx1 only: generally milder disease but still potential for complications; maintain avoidance of antibiotics and monitor, especially in children <5 years and older adults 1, 2.

Common pitfalls to avoid

• Starting antibiotics or loperamide in suspected/confirmed STEC—linked to worse outcomes 1.
• Assuming non‑O157 is benign—stx2+ non‑O157 can cause HUS and significant morbidity 1.
• Skipping culture after a positive toxin PCR—an isolate is critical for serogrouping and public health action 1.

Nuances and evidence notes

• Guideline consensus (CDC MMWR): stx2 correlates most with severe disease; early volume expansion may reduce renal damage; always avoid antibiotics; culture plus toxin testing is standard 1.
• Recent epidemiology supports stronger association of stx2 with bloody diarrhea, hospitalization, and HUS across serogroups, reinforcing risk focus on stx2 detection 2.